001     145606
005     20231212102435.0
024 7 _ |a 10.1109/CIG.2019.8848110
|2 doi
037 _ _ |a DZNE-2020-00936
041 _ _ |a English
100 1 _ |a Streck, Adam
|0 P:(DE-2719)2812503
|b 0
|e First author
|u dzne
111 2 _ |a 2019 IEEE Conference on Games (CoG)
|c London
|d 2019-08-20 - 2019-08-23
|w United Kingdom
245 _ _ |a Neomento - Towards building a universal solution for virtual reality exposure psychotherapy
260 _ _ |c 2019
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a Other
|2 DataCite
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a LECTURE_SPEECH
|2 ORCID
336 7 _ |a Conference Presentation
|b conf
|m conf
|0 PUB:(DE-HGF)6
|s 1702373031_1340
|2 PUB:(DE-HGF)
|x Other
520 _ _ |a We present the neomento project, a solution for virtual reality (VR) exposure therapy (VRET). In our work we have created specific rendering methods and virtual environments (VEs), designed and published a novel form of behavioural control for virtual agents (VA), included biophysiological measurements directly into the experience, and created an asymmetric gameplay system to assure the correct progress of a therapy session. The combination of above allows us to overcome multiple of the limitations that were hindering the previously published VRET solutions.
536 _ _ |a 341 - Molecular Signaling (POF3-341)
|0 G:(DE-HGF)POF3-341
|c POF3-341
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
588 _ _ |a Dataset connected to CrossRef Conference
700 1 _ |a Stepnicka, Philipp
|0 P:(DE-2719)2812507
|b 1
|u dzne
700 1 _ |a Klaubert, Jens
|0 P:(DE-2719)2812504
|b 2
|u dzne
700 1 _ |a Wolbers, Thomas
|0 P:(DE-2719)2810583
|b 3
|e Last author
|u dzne
773 _ _ |a 10.1109/CIG.2019.8848110
856 4 _ |u https://ieeexplore.ieee.org/document/8848110
856 4 _ |u https://pub.dzne.de/record/145606/files/DZNE-2020-00936_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/145606/files/DZNE-2020-00936_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:145606
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2812503
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2812507
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2812504
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2810583
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-341
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Molecular Signaling
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2019
920 1 _ |0 I:(DE-2719)1810004
|k AG Schmitz
|l Network Dysfunction
|x 0
920 1 _ |0 I:(DE-2719)1310002
|k AG Wolbers
|l Aging, Cognition and Technology
|x 1
980 _ _ |a conf
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1810004
980 _ _ |a I:(DE-2719)1310002
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21